Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project

May 5, 2021 updated by: Fondazione Don Carlo Gnocchi Onlus

Sport, Rehabilitation and Nutrition in Multiple Sclerosis: An Innovative Multidisciplinary High Impact Intervention for the Lifestyle Change

Only a limited percentage of persons with MS (pwMS) participate to multidisciplinary rehabilitation because of poor support, knowledge and motivation. The investigators reasoned that pwMS should be more effectively prepared to increase their adherence. This study propose the implementation of an innovative collaborative approach, called "brief high-impact preparatory experience" (b-HIPE), inspired by an overarching model based on the interplay between competence, motivation and opportunity to increase in a short time awareness and motivation of pwMS.

The aim of the study is the evaluation of its feasibility. For this pilot study the investigator chose a single-group design with repeated measurements at baseline and post intervention.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Milan, Italy
        • Recruiting
        • IRCCS Fondazione Don Carlo Gnocchi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 18 to 70 years
  • EDSS ranging from 1 to 7.5.
  • pwMS with who are on a western diet
  • stabilized medical therapy and clinical conditions
  • pwMS with a motor control of upper limbs sufficient to maneuver a tiller

Exclusion Criteria:

  • Heavy smoking, alcohol and drugs abuse
  • severe cognitive impairment
  • dysphagia and/or comorbidities requiring protected environments and specific medical assistance
  • blindness and severe visual disturbances (included severe nystagmus)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
A group of pwMS participate in a multidimensional integrate high-motivating rehabilitation program for the change of lifestyle and bad habits.
The intervention consists in a one-week intensive rehabilitation in which participants underwent to a multidimensional rehabilitation composed by physical rehabilitation, mental wellbeing, a proper diet and engaging physical activity (a sail course). Digital motivating reinforcements are proposed to the participants with the aim to maintain the correct lifestyle learned in the B-HIPE program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FS-36 Health Related Quality of Life (HRQoL)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Questionnaire to Measure Health-Related Quality of Life
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
The Fatigue Severity Scale (FSS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Questionnaire to Measure the fatigue
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Food frequency questionnaire (FFQ)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Questionnaire to evaluate usual frequency of foods and beverages
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MSIS29- Multiple Sclerosis Impact Scale
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
A scale for the evaluation of the impact of MS on day-to-day life
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
MOS Sleep Scale (MOSS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
A scale for the evaluation of the quality and the quantity of sleep
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Restless Legs Scale (RLS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
A scale for the evaluation of the restless legs syndrome
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Six minute walking test (6MWT)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
An exercise test used to assess aerobic capacity and endurance
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)
A self-assessment scale for detecting states of depression and anxiety
Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2018

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

June 30, 2022

Study Registration Dates

First Submitted

April 28, 2021

First Submitted That Met QC Criteria

May 5, 2021

First Posted (Actual)

May 11, 2021

Study Record Updates

Last Update Posted (Actual)

May 11, 2021

Last Update Submitted That Met QC Criteria

May 5, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Subscribe